Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

Study ID: NCT03838926
Start Date: 2018-09-27
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

42

Intervention / Treatment

Trichostatin A

Sponsor

Vanda Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Multi-Cancer Early Detection (MCED) of Firefighters

Study ID: NCT05780957
Start Date: 2023-03-21
End Date: 2030-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

Mced

Sponsor

Winning Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Molecular Epidemiology of Pediatric Germ Cell Tumors

Study ID: NCT05564026
Start Date: 2023-04-12
End Date: 2027-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1151

Intervention / Treatment

Administration questionnaire

Tumor Specimen Collection

Germline DNA Samples

Blood Sample Collection

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Study ID: NCT03769766
Start Date: 2019-03-11
End Date: 2030-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

291

Intervention / Treatment

Curcumin

Placebo

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Study ID: NCT05493566
Start Date: 2022-11-01
End Date: 2027-01-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

15

Intervention / Treatment

Aldesleukin

Pembrolizumab

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab

Study ID: NCT03767348
Start Date: 2017-09-20
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

340

Intervention / Treatment

RP1

Nivolumab

Sponsor

Replimune Inc.

Source: clinicaltrials.gov

Share:
Add to list

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Study ID: NCT03127774
Start Date: 2017-09-22
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Cisplatin

Sodium thiosulfate

Cytoreductive surgery

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Study ID: NCT05669430
Start Date: 2023-03-23
End Date: 2027-09-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

365

Intervention / Treatment

GV20-0251

GV20-0251

GV20-0251 and Pembrolizumab [KEYTRUDA®]

GV20-0251 and Pembrolizumab [KEYTRUDA®]

Sponsor

GV20 Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Telehealth and Memory Study

Study ID: NCT04586530
Start Date: 2021-03-18
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

220

Intervention / Treatment

Memory and Attention Adaptation Training (MAAT)

Supportive Therapy (ST)

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment

Study ID: NCT05928325
Start Date: 2021-06-17
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Comprehensive Geriatric Assessment

Health Education

Medical Device Usage and Evaluation

Supportive Care

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list